We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Nastech Pharmaceutical announced that the U.S. National Institute of Allergy and Infectious Diseases, a division of the NIH, awarded the company a Small Business Innovation Research grant.
The Australian and New Zealand governments have called for further comments from industry on the proposed Australia New Zealand Therapeutic Products Authority (ANZTPA).
Generex Biotechnology Corporation, the leader in metabolic diseases drug delivery through the inner lining of the mouth, announced that it has been granted a new patent by the Mexican Institute of Industrial Property titled Pharmaceutical Compositions for Buccal and Pulmonary Application.
Banyu Pharmaceutical and Maruho Co., Ltd. have announced that an additional indication of Stromectol Tablets 3mg -- generic name ivermectin -- has been approved for the administration for scabies treatment under the Nippon Health Insurance (NHI) system, alleviating patients' payment for the drug themselves.
WEX Pharmaceuticals Inc. ("WEX" or the"Company") is pleased to announce official grant to the Company patent ZL 01 1 18098.6 by the State Intellectual Property Office of the People's Republic of China (SIPO) under the title of "Application of A Synergistic Combination of A Sodium Ion Channel Blocker and An Opioid Analgesic in Treatment of Pain in Mammals" and patent UA 2003032528 by the State Department of Intellectual Property of Ukraine under the title "Method of Analgesia".
Carrington Laboratories, Inc, a research-based biopharmaceutical and consumer products company, announced the issuance of Chinese Patent No. ZL 02807315.0 entitled "In Situ Gel Formation of Pectins" which relates to the company's proprietary GelSite polymer technology.